Evidence map›Paper›PMID 23756094›Full record

ReviewTrends in cell biology2013

Emerging roles for ribonucleoprotein modification and remodeling in controlling RNA fate.

Suzanne R Lee, Jens Lykke-Andersen

Open access · greenAbstract readReview
In one paragraph

Review in Trends in cell biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. RBPs: an RNA editor's choice.Frontiers in molecular biosciences · 2024
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Functional Features and Current Applications of the RNA-Targeting Type VI CRISPR-Cas Systems.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Review
  8. Review
  9. RNA-protein interaction mapping via MS2- or Cas13-based APEX targeting.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. A brave new world of RNA-binding proteins.Nature reviews. Molecular cell biology · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Suzanne R LeeDivision of Biological Sciences, University of California San Diego, La Jolla, CA 92093, USA. Electronic address: suzannerlee@gmail.com.
Jens Lykke-Andersen
University of California, San Diego · US

Funding

Mechanisms of mRNP remodeling in mRNA turnoverR01GM099717 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LYKKE-ANDERSEN, JENS · 2012 to 2015
$1.2M
NIGMS NIH HHS R01 GM099717
6 · The paper itself

Abstract

In the cell, mRNAs and non-coding RNAs exist in association with proteins to form ribonucleoprotein (RNP) complexes. Regulation of RNP stability and function is achieved by alterations to the RNP through poorly understood mechanisms into which recent studies have now begun to provide insight. This emerging body of work points to chemical modification of RNPs at the RNA or protein level and ATP-dependent RNP remodeling by RNA helicases/RNA-dependent ATPases as central events that dictate RNA fate. Some RNP modifications serve as tags for recruitment of regulatory proteins, with RNP modifiers and recruited proteins analogous to the writers and readers of chromatin modification, respectively. This review highlights examples in which RNP modification and ATP-dependent remodeling play key roles in the control of eukaryotic RNA fate, suggesting that we are only at the beginning of uncovering the multitude of ways in which RNP modification and remodeling impact RNA regulation.

Indexed as

Adenosine TriphosphateCytoplasmHumansRibonucleoproteinsRNARNA, MessengerRNA, UntranslatedAdenosine TriphosphateRibonucleoproteinsRNARNA, MessengerRNA, Untranslatedpost-translational modificationribonucleotidyltransferaseRNA decayRNA helicaseRNA modificationRNA tailingRNP modificationuridylation

Identifiers

PMID23756094
PMCPMC3983964
OpenAlexW1977324313

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.